(Q38940698)

7 September 2017

Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma (English)

1 reference

7 September 2017

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Y Shimazu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

T Ichikawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

K Fujii

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

M Onishi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

J Ishida

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

T Oka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

M Watanabe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Y Nasu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

H Kumon

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

I Date

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

13 November 2014

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

146-154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2014.100

8 June 2020

exact match

0 references

cites work

Molecularly targeted therapies for malignant gliomas: advances and challenges

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

REIC/Dkk-3 induces cell death in human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Integrins in angiogenesis: multitalented molecules in a balancing act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Gene expression profiling of the anti-glioma effect of Cilengitide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Cilengitide treatment for malignant glioma: current status and future direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Integrin regulation of beta-catenin signaling in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.100

Tumor angiogenesis and the role of vascular cell integrin alphavbeta3.

21 January 2018

1 reference

12 December 2020

Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts

1 reference

12 December 2020

Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma

1 reference

12 December 2020

The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma.

1 reference

12 December 2020

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

12 December 2020

Identifiers

DOI

10.1038/GT.2014.100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394252%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 June 2020

1014885695

0 references

Fatcat ID

release_hf7yixvkwvb6nbtnavsw4hcw2a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hf7yixvkwvb6nbtnavsw4hcw2a

24 November 2022

mapped directly with Wikidata item

1 reference